Skip to main
DCGO

DocGo (DCGO) Stock Forecast & Price Target

DocGo (DCGO) Analyst Ratings

Based on 4 analyst ratings
Buy
Strong Buy 50%
Buy 25%
Hold 25%
Sell 0%
Strong Sell 0%

Bulls say

DocGo is a mobile health and medical mobility solutions provider with a majority of its revenue coming from the United States. While the company has recently experienced a decline in organic revenue growth, the addition of SteadyMD has provided a significant boost. The company has faced challenges in staffing and overtime costs in its Transportation Services segment, but is making progress in filling open positions. Additionally, the company is expanding its relationship with a top 10 national insurance payer and continues to experience growth in patient volumes across various programs.

Bears say

DocGo is experiencing difficulties in scaling its go-forward business and faces challenges in ramping up its core payer business while staying profitable. The company's recent acquisitions, such as SteadyMD, have shown promise but may not be enough to offset the decline in organic non-migrant Mobile Health revenue. The company has a solid foundation in its core transportation business, but its current valuation is discounted due to ongoing struggles and uncertainty in the company's future profitability. With a HOLD rating, further improvements and progress in scaling its business are needed before gaining confidence in the company's outlook.

DocGo (DCGO) has been analyzed by 4 analysts, with a consensus rating of Buy. 50% of analysts recommend a Strong Buy, 25% recommend Buy, 25% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of DocGo and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About DocGo (DCGO) Forecast

Analysts have given DocGo (DCGO) a Buy based on their latest research and market trends.

According to 4 analysts, DocGo (DCGO) has a Buy consensus rating as of Jul 19, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $2.38, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $2.38, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

DocGo (DCGO)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.